Compare ATRC & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | INSP |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.2B |
| IPO Year | 2005 | 2018 |
| Metric | ATRC | INSP |
|---|---|---|
| Price | $29.95 | $53.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 16 |
| Target Price | $51.17 | ★ $101.07 |
| AVG Volume (30 Days) | 545.5K | ★ 1.0M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 74.74 | ★ 179.43 |
| EPS | N/A | ★ 4.89 |
| Revenue | ★ $201,630,000.00 | $82,050,000.00 |
| Revenue This Year | $15.17 | $8.44 |
| Revenue Next Year | $12.42 | $8.60 |
| P/E Ratio | ★ N/A | $11.02 |
| Revenue Growth | 15.40 | ★ 62.18 |
| 52 Week Low | $28.32 | $53.11 |
| 52 Week High | $43.18 | $172.95 |
| Indicator | ATRC | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 30.16 |
| Support Level | $28.69 | $53.11 |
| Resistance Level | $32.85 | $84.26 |
| Average True Range (ATR) | 1.14 | 2.82 |
| MACD | 0.20 | -0.03 |
| Stochastic Oscillator | 37.59 | 11.18 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.